Last reviewed · How we verify
IUCD
At a glance
| Generic name | IUCD |
|---|---|
| Sponsor | ALshaimaa Aboalhassan Ali |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- procedural pain
- dysmenorrhoea
- menorrhagia
- metrorrhagia
- pelvic pain
- uterine spasm
- dyspareunia
- abdominal pain
- bacterial vaginosis
Key clinical trials
- A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer (PHASE2)
- SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer
- A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia (PHASE2)
- Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology (NA)
- Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation (NA)
- A Comparative Study Evaluating Pain Experienced During Intrauterine Device Insertion in Women
- 3 mL Inhaled Methoxyflurane for Intrauterine Device (IUD) Insertion (PHASE4)
- Transcutaneous Electrical Nerve Stimulation (TENS) for Intrauterine Device (IUD) Insertion Pain (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |